The Deal
Sunday, November 8, 
5:32 am

Big payday for Wrigley execs, including strategy SVP

Posted on April 29, 2008 at 12:52 PM
Filed under: Acquisitions | Integration | People
Tagged: , , , , ,
[ Share ]  [ E-mail ]  [ Leave a Comment ]
PeterHempsteadBig.png Mars Inc.'s $23 billion acquisition of Wm. Wrigley Jr. Co. will produce some big paydays for key execs at the target. Take Wrigley's dealmaker Peter Hempstead, for example. The senior vice president of worldwide strategy and new business will reap $15.94 million from the sale of his stock, according to Chicago Business.

Hempstead, responsible for M&A, PMI and competitive intelligence gathering, joined Wrigley in 1999 and also leads its businesses in Western Europe.  Before Wrigley he spent 23 years with Procter & Gamble Co., where his assignments included serving as vice president and general manager in China, running operations in Scandinavia and serving as VP of European pharmaceutical operations.

Hempstead (pictured) isn't the only one pulling in a nice sum: Chicago Business reported that CEO William Perez will receive $11.4 million from the sale of stock and that Dushan Petrovich, SVP and CAO, will get $34 million. William Wrigley Jr. will receive $1.36 billion.

Given the nature of the plans for bringing the companies together, the big checks are an interesting wrinkle in the deal. Mars says it wants Wrigley execs to keep running the business, and that it will turn a couple of big nonchocolate products over to them. As we discussed in a recent article on integrating executive comp, it's sometimes difficult to retain execs who get significant sums as a result of a deal.  - Baz Hiralal

Go to the story from Crain's Chicago Business
Go to the Wm. Wrigley-Mars article from TheDeal.com
See the Dealwatch, Confectioners: Mars, Wrigley, Cadbury and Hershey


Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Linklaters' Schmidt on Pfizer-Wyeth review

Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.
Decade of The Deal


Movers & Shakers


Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.
Eric Hausler, Isle of Capri Casinos Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.